Jonne Terstappen

Dr. Jonne Terstappen, MD MSc, is a clinician-investigator at the Center of Translational Immunology, Wilhelmina Children's Hospital (UMC Utrecht), Netherlands, specializing in infectious disease research, RSV vaccinations, and monoclonal antibody therapies. Her work focuses on developing immunological interventions for infants in low- and middle-income countries, ensuring equitable access to life-saving treatments.

Dr. Terstappen earned her medical degree from Utrecht University, following her cum laude graduation in liberal arts and sciences from University College Utrecht. She has been actively involved in global health research, refining preventive strategies for respiratory syncytial virus (RSV) infections. Her contributions to monoclonal antibody development aim to improve long-term immunity and reduce RSV-related mortality in vulnerable populations.

Her research has been recognized with the Royal Holland Society of Sciences and Humanities Award, highlighting her impact on infectious disease prevention. She has published in peer-reviewed journals, including The Lancet Infectious Diseases, contributing to scientific discussions on RSV vaccine accessibility and immunotherapy advancements.

Beyond her research, Dr. Terstappen is committed to global health equity, advocating for affordable and scalable immunization programs. She collaborates with international health organizations, ensuring that low-resource settings benefit from cutting-edge medical innovations. Her work integrates clinical expertise with translational immunology, bridging the gap between scientific discovery and real-world healthcare applications.

‍